BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26153495)

  • 21. The Role of BRAF in Metastatic Colorectal Carcinoma-Past, Present, and Future.
    Djanani A; Eller S; Öfner D; Troppmair J; Maglione M
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratumor morphologic and transcriptomic heterogeneity in
    Angerilli V; Fontana E; Lonardi S; Sbaraglia M; Borelli B; Munari G; Salmaso R; Guzzardo V; Spolverato G; Pucciarelli S; Pilati P; Hahne JC; Bergamo F; Zagonel V; Dei Tos AP; Sadanandam A; Loupakis F; Valeri N; Fassan M
    ESMO Open; 2021 Aug; 6(4):100211. PubMed ID: 34271310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucin phenotype and genetic alterations in non-V600E BRAF-mutated colorectal cancer.
    Ozeki H; Shimada Y; Nakano M; Kondo S; Ohashi R; Miwa Y; Yamai D; Matsumoto A; Abe K; Tajima Y; Ichikawa H; Sakata J; Takii Y; Sugai M; Nagai T; Ling Y; Okuda S; Wakai T
    Hum Pathol; 2024 Mar; 145():71-79. PubMed ID: 38423222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer.
    Yaeger R; Chatila WK; Lipsyc MD; Hechtman JF; Cercek A; Sanchez-Vega F; Jayakumaran G; Middha S; Zehir A; Donoghue MTA; You D; Viale A; Kemeny N; Segal NH; Stadler ZK; Varghese AM; Kundra R; Gao J; Syed A; Hyman DM; Vakiani E; Rosen N; Taylor BS; Ladanyi M; Berger MF; Solit DB; Shia J; Saltz L; Schultz N
    Cancer Cell; 2018 Jan; 33(1):125-136.e3. PubMed ID: 29316426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating tumor DNA, and clinical features to guide rechallenge with BRAF inhibitors in BRAF-V600E mutated metastatic colorectal cancer.
    Ros J; Vivancos A; Tabernero J; Élez E
    Ann Oncol; 2024 Feb; 35(2):240-241. PubMed ID: 37866812
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinicopathologic Features and Prognosis of
    Guan WL; Qiu MZ; He CY; Yang LQ; Jin Y; Wang ZQ; Li YH; Xu RH; Wang FH
    Front Oncol; 2020; 10():563407. PubMed ID: 33330032
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro differential sensitivity of melanomas to phenothiazines is based on the presence of codon 600 BRAF mutation.
    Ikediobi ON; Reimers M; Durinck S; Blower PE; Futreal AP; Stratton MR; Weinstein JN
    Mol Cancer Ther; 2008 Jun; 7(6):1337-46. PubMed ID: 18524847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicogenomic Characteristics and Treatment of Young-Onset Colorectal Cancer Patients Treated With Palliative Therapy in Real-World Practice.
    Jeong H; Lee E; Kim D; Kim J; Kim SY; Hong YS; Kim TW; Kim JE
    Cancer Control; 2022; 29():10732748221096842. PubMed ID: 35475677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial-Driven Inflammation and Mutant
    DeStefano Shields CE; White JR; Chung L; Wenzel A; Hicks JL; Tam AJ; Chan JL; Dejea CM; Fan H; Michel J; Maiuri AR; Sriramkumar S; Podicheti R; Rusch DB; Wang H; De Marzo AM; Besharati S; Anders RA; Baylin SB; O'Hagan HM; Housseau F; Sears CL
    Cancer Discov; 2021 Jul; 11(7):1792-1807. PubMed ID: 33632774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRAF p.V600E Mutational Status Does Not Correlate with Biological Behavior in Conventional Ameloblastomas: A Disease-Free Survival Analysis.
    Martins-de-Barros AV; da Costa Araújo FA; Faro TF; de Aquino AAT; Barbosa Neto AG; da Silva HAM; de Lima ELS; Muniz MTC; de Oliveira E Silva ED; de Vasconcelos Carvalho M
    Head Neck Pathol; 2024 Mar; 18(1):23. PubMed ID: 38504068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRAF
    Rzasa P; Whelan S; Farahmand P; Cai H; Guterman I; Palacios-Gallego R; Undru SS; Sandford L; Green C; Andreadi C; Mintseva M; Parrott E; Jin H; Hey F; Giblett S; Sylvius NB; Allcock NS; Straatman-Iwanowska A; Feuda R; Tufarelli C; Brown K; Pritchard C; Rufini A
    Commun Biol; 2023 Sep; 6(1):962. PubMed ID: 37735514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinicopathological features of adult Wilms tumor with BRAF V600E mutation].
    Gan HL; Wang QF; Zhu XL; Lyu H; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1210-1215. PubMed ID: 38058036
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal Cancer Patients: An Exploratory Study.
    Cayún JP; Cerpa LC; Colombo A; Cáceres DD; Leal JL; Reyes F; Gutiérrez-Cáceres C; Calfunao S; Varela NM; Quiñones LA
    Curr Oncol; 2024 Jan; 31(1):274-295. PubMed ID: 38248103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: a case report and review of the literature.
    Ricco G; Seminerio R; Andrini E; Malvi D; Gruppioni E; Altimari A; Zagnoni S; Campana D; Lamberti G
    Anticancer Drugs; 2023 Nov; 34(10):1076-1084. PubMed ID: 36847048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of
    Takeda H; Sunakawa Y
    Front Oncol; 2021; 11():602194. PubMed ID: 33842313
    [No Abstract]   [Full Text] [Related]  

  • 36. Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study.
    Cremolini C; Pietrantonio F; Tomasello G; Dadduzio V; Moretto R; Morano F; Schirripa M; Antoniotti C; Fucà G; Bergamo F; Rossini D; Nichetti F; Ziampiri S; Ghidini M; Marmorino F; Prisciandaro M; Falcone A; De Braud F; Loupakis F; Lonardi S
    ESMO Open; 2017; 2(3):e000241. PubMed ID: 29209533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Device-assisted Full Thickness R0 Resection of BRAF (V600E)-Mutated T3 Colorectal Cancer in the Ascending Colon.
    Zimmer V; Schuld J
    J Gastrointestin Liver Dis; 2023 Dec; 32(4):431. PubMed ID: 38147597
    [No Abstract]   [Full Text] [Related]  

  • 38. BRAF p.V600E mutation as a molecular boundary between genuine oligo-repeated and poly-metastatic disease in colorectal cancer.
    Ottaiano A; Santorsola M; Circelli L; Ianniello M; Casillo M; Petrillo N; Sabbatino F; Cascella M; Perri F; Capuozzo M; Albino V; Granata V; Izzo F; Di Mauro A; Berretta M; Ruggiero R; Gualillo O; Sirica R; Nasti G; Savarese G
    Neoplasia; 2023 Oct; 44():100930. PubMed ID: 37634281
    [No Abstract]   [Full Text] [Related]  

  • 39. An unusual form of BRAF-V600E mutated hairy cell neoplasm with clinical resistance to BRAF inhibition: Challenging precision medicine.
    Marra A; Santi A; Pucciarini A; Venanzi A; De Carolis L; Zaja F; Ascani S; Canzonieri V; Ballanti S; Falini B; Tiacci E
    Am J Hematol; 2024 Mar; 99(3):497-501. PubMed ID: 38264797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCL16 promotes tumor metastasis by regulating angiogenesis in the tumor micro-environment of BRAF V600E mutant colorectal cancer.
    Deng W; Liu X; Huang S; Wu Z; Alessandro F; Lin Q; Cai Z; Zhang Z; Huang Y; Wang H; Yuan Z
    Transl Oncol; 2024 Mar; 41():101854. PubMed ID: 38232513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.